Principal Investigator
Division of General Internal Medicine
Division of Thoracic Medicine
更新時間：2023-09-19
- Principal Investigator
- Clinical Trial Experience (year) 12 years 9 個月
Highlights
Study Area
- A Phase 3 Study to Evaluate Zimberelimab (AB122) Monotherapy Compared to Standard Chemotherapy or Zimberelimab Combined with AB154 in Front-Line, PD-L1-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- A Phase 2 trial of durvalumab (MEDI4736) and tremelimumab with chemotherapy in metastatic EGFR mutant non-squamous non-small cell lung cancer (NSCLC) following progression on EGFR Tyrosine Kinase Inhibitors (TKIs)
Professional Experiences
Superintendent
asthma,
2015- 迄今
Education
Kaohsiung Medical College, Kaohsiung
Professor of Medicine
1975-1982
Clinical Trials List
2016
Total 146
-
I 14
-
I/II 7
-
II 29
-
II/III 7
-
III 84
-
IV 1
-
Others 4
Number of Studies by Scale
4件
Taiwan Multiple Center
Taiwan Single Center
1Cases
Taiwan Multiple Center
4Cases
Multi-Regional Multi-Center
140Cases
